Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.03
Delayed Data
As of Jul 21
 -0.018 / -0.59%
Today’s Change
2.61
Today|||52-Week Range
9.76
-48.29%
Year-to-Date
Institutional investors purchased a net $51.2 thousand shares of NVGN during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 1.51% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional1.51%
Mutual fund holders0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Novogen Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC0.71%137,300123,57000.00%
Morgan Stanley & Co. LLC0.65%124,600112,140+28,500+29.66%
Citadel Advisors LLC0.07%12,75111,476+12,751--
UBS Securities LLC0.04%8,1097,298+4,353+115.89%
RBC Capital Markets LLC (Investme...0.03%5,0004,500+4,870+3,746.15%
Morgan Stanley Smith Barney LLC (...0.01%2,7242,45200.00%
Marketocracy Capital Management L...0.00%800720+800--
UBS Financial Services, Inc.0.00%83775300.00%
Creative Planning, Inc.0.00%20018000.00%
Merrill Lynch, Pierce, Fenner & S...0.00%22019800.00%

Top 10 Mutual Funds Holding Novogen Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change